{"id":"W4387722601","doi":"10.1200/jco.22.02770","title":"Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Gemcitabine; Erlotinib; Medicine; Internal medicine; Pancreatic cancer; Oncology; Erlotinib Hydrochloride; Hazard ratio; Adverse effect; Placebo; Clinical endpoint; Cancer; Clinical trial; Epidermal growth factor receptor; Pathology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00233869,0.001374934,0.002619717,0.0003694274,0.0005040903,0.0009716155,0.0007510698,0.00114932,0.003349441],"category_scores_gemma":[0.001740342,0.0003808165,0.001850514,0.0006641564,0.0008199848,0.0004851311,0.0002824148,0.002682643,0.0003492358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002354959,"about_ca_system_score_gemma":0.003641962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01643462,"about_ca_topic_score_gemma":0.04779255,"domain_scores_codex":[0.9991972,0.000508122,0.00003947386,0.00008521143,0.0000727183,0.00009743385],"domain_scores_gemma":[0.9991641,0.0001788586,0.0002451074,0.00004214172,0.00008282333,0.0002869454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9582358,0.004087462,0.0009383114,0.0008512022,0.00132499,0.00002936528,0.00004505583,0.0006014607,0.001265235,0.0001053,0.002127713,0.0303882],"study_design_scores_gemma":[0.9447216,0.04723979,0.00461894,0.00007800513,0.001013502,0.00003870044,0.0000242056,0.0006266867,0.0002600779,0.000108476,0.001252301,0.00001786536],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9587039,0.02426399,0.0005573945,0.002965242,0.0007560966,0.005602508,0.002298892,0.0001123163,0.004739692],"genre_scores_gemma":[0.9737996,0.01217401,0.001840171,0.002028579,0.0005787922,0.003558742,0.001552989,0.0000199685,0.004447062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01643462,"threshold_uncertainty_score":0.03267789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2282766189847739,"score_gpt":0.5345134374092202,"score_spread":0.3062368184244463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}